Sign in to fuzzto save your conversations, follow your research and come back anytime.
Fredun Pharmaceuticals
SectorHealthcare
| Metric (₹ crore) | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 288.86 | 167.41 | 119.85 | 145.3 | 160.93 | 213.05 | 228.25 |
| Expenses | 0 | 0 | 251.2 | 150.16 | 102.86 | 122.96 | 134.59 | 184.17 | 195.51 |
| EBITDA | 0 | 0 | 37.66 | 17.25 | 16.99 | 22.34 | 26.34 | 28.88 | 32.74 |
| Depreciation | 0 | 0 | 3.2 | 1.84 | 1.42 | 1.89 | 1.78 | 3.15 | 3.57 |
| EBIT | 0 | 0 | 34.46 | 15.41 | 15.57 | 20.45 | 24.56 | 25.73 | 29.17 |
| Interest | 0 | 0 | 14.23 | 8.15 | 6.53 | 7.73 | 10.55 | 14.49 | 8.62 |
| Profit Before Tax | 0 | 0 | 20.23 | 7.26 | 9.04 | 12.72 | 14.01 | 11.24 | 20.55 |
| Net Profit | 0 | 0 | 13.74 | 6 | 6.77 | 9.43 | 10.48 | 10.78 | 13.13 |
| EPS | 0 | 0 | 29.09 | 12.71 | 14.33 | 19.98 | 22.19 | 19.7 | 23.82 |
| Metric (₹ crore) | FY25 | FY26 |
|---|---|---|
| Operating Cash Flow | -16.6 | 11.9 |
| Investing Cash Flow | -6.35 | -73.59 |
| Financing Cash Flow | 26.65 | 121.45 |
| Net Cash Flow | 3.7 | 59.76 |
| Metric (₹ crore) | FY25 | FY26 |
|---|---|---|
| Equity / Shareholders' Funds | 141.38 | 278.11 |
| Total Liabilities | 346.03 | 363.97 |
| Total Assets | 487.41 | 642.08 |